002275.SZ
桂林三金
SZSE · Healthcare · C 制造业 · CN
CNY 12.57
−4.99%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
10.3x
Market Cap
CNY 7.39B
MomentumView details →
1D Return
−4.99%
YTD Return
−12.34%
RSI (14)
36.5
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
10.3x
Market Cap
CNY 7.39B
RSI (14)
36.5
MomentumView details →
1D Return
−4.99%
YTD Return
−12.34%
Similar companies
Latest newsMore news →
Guilin Sanjin's wholly-owned subsidiary Hunan Sanjin was provisionally selected in the 12th national centralized drug procurement for lamotrigine tablets, with the procurement period running until December 31, 2029.33d agoGuilin Sanjin Pharmaceutical Co., Ltd. provided guarantees totaling 60 million yuan for its wholly-owned subsidiaries Baochuan Bio and Baifan Bio to increase their credit lines with Xiamen International Bank Shanghai Branch.40d ago